Patient and treatment characteristics and safety outcomes of patients with relapsing-remitting multiple sclerosis treated with natalizumab in Greece: Results from the multicenter, 5-year prospective observational study ‘TOPICS greece’

BACKGROUND: Natalizumab is a highly efficacious treatment for relapsing-remitting multiple sclerosis (RRMS). OBJECTIVE: To assess the real-world long-term safety of natalizumab in RRMS. METHODS: This multicenter, 5-year prospective observational study, included adults with RRMS newly initiated on na...

Descripción completa

Detalles Bibliográficos
Autores principales: Karanasios, Panagiotis, Karachalios, Georgios, Gourgioti, Rania, Alexopoulou, Antonia, Mastorodemos, Vasileios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327250/
https://www.ncbi.nlm.nih.gov/pubmed/34377528
http://dx.doi.org/10.1177/20552173211035803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327250/
https://www.ncbi.nlm.nih.gov/pubmed/34377528
http://dx.doi.org/10.1177/20552173211035803

Ejemplares similares